Data / Form D filings / MBF Therapeutics, Inc.
MBF Therapeutics, Inc.: Form D filings
MBF Therapeutics, Inc., a biotechnology company in Ambler, PA, filed 9 Form D notices with the SEC between 2009 and 2024. The latest, on January 8, 2024, reports $105,000 sold of a $500,000 offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 640 WOODBROOK DRIVE, Ambler, PA, 19002
- Phone
- (215) 620-3699
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1458729
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 8, 2024 | New notice | $500,000 | $105,000 | $395,000 | 6 | Dec 29, 2023 | sec.gov |
| Sep 21, 2021 | Amendment | $3,000,000 | $814,292 | $2,185,708 | 21 | Aug 20, 2020 | sec.gov |
| Sep 1, 2020 | New notice | $3,000,000 | $604,292 | $2,395,708 | 16 | Aug 20, 2020 | sec.gov |
| May 24, 2019 | Amendment | $2,000,000 | $605,000 | $1,395,000 | 16 | Oct 11, 2017 | sec.gov |
| May 2, 2018 | Amendment | $2,000,000 | $425,000 | $1,575,000 | 10 | Oct 11, 2017 | sec.gov |
| Nov 16, 2017 | New notice | $1,000,000 | $130,000 | $870,000 | 2 | Oct 11, 2017 | sec.gov |
| Nov 21, 2016 | New notice | $1,095,185 | $1,095,185 | 14 | Nov 10, 2016 | sec.gov | |
| Mar 15, 2010 | Amendment | $1,010,000 | $345,000 | $665,000 | 7 | Mar 5, 2009 | sec.gov |
| Mar 17, 2009 | New notice | $750,000 | $100,000 | $650,000 | 2 | Mar 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dhiren Thakker | Director | |
| Joseph Connor | Director | |
| Aris Persidis | Director | |
| Lorraine Keller | Executive Officer | |
| Thomas Tillett | Executive Officer, Director | |
| Christopher Cashman | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jan 8, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MBF Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.